Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
Clinical trial NCT04333147 · TERMINATED
Trial details
- NCT number
- NCT04333147
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2023-02-24
- Enrollment
- 2916
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.